Dr Svetlana Evans

2021

• Wong, E. et al., 2021. C3 Glomerulopathy and related disorders in children. Clinical Journal of the American Society of Nephrology 16 (11), pp.1639-1651. (10.2215/CJN.00320121)

2019

• Shimauchi, T. et al. 2019. Dendritic cells promote the spread of human T-cell leukemia virus type 1 via bidirectional interactions with CD4+ T cells. Journal of Investigative Dermatology 139 (1), pp.157-166. (10.1016/j.jid.2018.06.188)

2018

• Loveless, S. et al. 2018. Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosis. Brain Pathology 28 (4), pp.507-520. (10.1111/bpa.12546)

2017

• Hakobyan, S. et al. 2017. Plasma complement biomarkers distinguish multiple sclerosis and neuromyelitis optica spectrum disorder. Multiple Sclerosis Journal 23 (7), pp.946-955. 135245851666900. (10.1177/1352458516669002)

2016

• Caucheteux, S. M. et al. 2016. Polypropylene sulfide nanoparticle p24 vaccine promotes dendritic cell-mediated specific immune responses against HIV-1. Journal of Investigative Dermatology 136 (6), pp.1172-1181. (10.1016/j.jid.2016.01.033)

2014

• Clark, S. J. et al., 2014. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration. The Journal of Immunology 193 (10), pp.4962-4970. (10.4049/jimmunol.1401613)
• Ingram, G. et al. 2014. Complement activation in MS: An immunohistochemical analysis. Journal of Neurology, Neurosurgery & Psychiatry 85 (10), pp.e4.13. (10.1136/jnnp-2014-309236.11)

2013

• Clark, S. J. et al., 2013. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions. The Journal of Immunology 190 (5), pp.2049-2057. (10.4049/jimmunol.1201751)
• Goicoechea de Jorge, E. et al., 2013. Dimerization of complement factor H-related proteins modulates complement activation in vivo. Proceedings of the National Academy of Sciences of the United States of America 110 (12), pp.4685-4690. (10.1073/pnas.1219260110)
• Khandhadia, S. et al., 2013. Age-related macular degeneration and modification of systemic complement factor H production through liver transplantation. Ophthalmology 120 (8), pp.1612-1618. (10.1016/j.ophtha.2013.01.004)

2012

• Gibson, J. et al., 2012. Variation in complement component C1 inhibitor in age-related macular degeneration. Immunobiology 217 (2), pp.251-255. (10.1016/j.imbio.2011.07.015)
• Ingram, G. et al. 2012. Systemic complement profiling in multiple sclerosis as a biomarker of disease state. Multiple Sclerosis Journal 18 (10), pp.1401-1411. (10.1177/1352458512438238)
• McCully, M. L. et al. 2012. Epidermis instructs skin homing receptor expression in human T cells. Blood 120 (23), pp.4591-4598. (10.1182/blood-2012-05-433037)

2011

• Ingram, G. et al. 2011. Complement regulator factor H in multiple sclerosis. Journal of Cellular Biochemistry 112 (10), pp.2653-2654. (10.1002/jcb.23204)

2010

• Clark, S. J. et al., 2010. Impaired Binding of the Age-related Macular Degeneration-associated Complement Factor H 402H Allotype to Bruch's Membrane in Human Retina. Journal of Biological Chemistry 285 (39), pp.30192-30202. (10.1074/jbc.M110.103986)
• Hakobyan, S. et al. 2010. Variant-specific quantification of factor H in plasma identifies null alleles associated with atypical hemolytic uremic syndrome. Kidney International 78 (8), pp.782-788. (10.1038/ki.2010.275)
• Ingram, G. et al. 2010. Complement regulator factor H as a serum biomarker of multiple sclerosis disease state. Brain 133 (6), pp.1602-1611. (10.1093/brain/awq085)
• Ingram, G. et al. 2010. Elevated plasma C4a levels in multiple sclerosis correlate with disease activity. Journal of Neuroimmunology 223 (1-2), pp.124-127. (10.1016/j.jneuroim.2010.03.014)
• Johnson, S. A. et al., 2010. Impact of compound heterozygous complement factor H mutations on development of atypical hemolytic uremic syndrome - A pedigree revisited. Molecular Immunology 47 (7-8), pp.1585-1591. (10.1016/j.molimm.2009.12.001)

2009

• Ingram, G. et al. 2009. Complement in multiple sclerosis: its role in disease and potential as a biomarker. Clinical and Experimental Immunology 155 (2), pp.128-139. (10.1111/j.1365-2249.2008.03830.x)

2008

• Hakobyan, S. et al. 2008. Measurement of factor H variants in plasma using variant-specific monoclonal antibodies: application to assessing risk of age-related macular degeneration. Investigative Ophthalmology and Visual Science 49 (5), pp.1983-1990. (10.1167/iovs.07-1523)
• Hakobyan, S. et al. 2008. Complement factor H binds to denatured rather than to native pentameric C-reactive protein. Journal of Biological Chemistry 283 (45), pp.30451-30460. (10.1074/jbc.M803648200)